Select Page

dry eye syndrome and depressionPeople who have dry eye disease (DED) or dry eye syndrome also suffer from depression, anxiety, or stress.  There are many theories as to the cause:  The chronic pain associated with the symptoms of DED, certain medications that treat depression that cause dry eyes, or an underlying physical problem that causes depression that can also cause DED.  Fortunately, there are some ways to deal with DED and depression that bring people relief.

Dry Eye Syndrome

Resulting in damage to the surface of the eye, dry eye disease affects the tear production and ocular surface.  Vision problems, interference with reading, working, or driving, and complications such as conjunctivitis, ulcers, or scars can be caused from DED.  Itching, burning, redness, a feeling of something in the eye, and pain are a few of the symptoms of suffering from dry eyes.

Dry eye disease can affect anyone of any age.  However, it seems more prevalent in females and older individuals.  There are many factors that can cause dry eyes:  smoking, surgery, hormonal changes, poor indoor air quality, dry air, and contact lenses are just a few.  Experts have found that from one-third Up to half of a community can suffer from DED.

Depression and Dry Eye Syndrome

The symptoms associated with DED can have a negative effect on the quality of an individual’s life, mood, and mental health.  When symptoms are severe, the individual’s perception of pain along with depression, stress, and anxiety can be present.  It is also thought that those who do not suffer from DED initially may develop dry eye symptoms due to antidepressant medications.

The connection between depression symptoms and the symptoms of dry eyes is fairly stunning.  Patients that did not take psychiatric medications, but still suffered from depression, were found to have dry eye syndrome almost three times more than their counterparts.  If patients who take medication for depression are added into the mix, the numbers rise even higher.  Therefore, doctors are now becoming aware of the fact that many patients who have never been diagnosed with depression should be evaluated when diagnosed with DED.

How TheraLife Helps Dry Eye Syndrome

The entire line of TheraLife Eye products work by restoring normal health to cells that are injured or performing poorly due to inflammation. These proven formulas increase microcirculation and blood flow which, in turn, deliver vital nutrients and medication to injured sites and reduces inflammation.  When eyes are covered with protective tears, pain is eliminated and patients report relief.

If you currently suffer from chronic dry eyes, the TheraLife All-In-One Eye Enhanced Starter Kit is the perfect solution to help you find relief from dry eye symptoms and pain. By reducing irritation and inflammation of the tear glands, eyelids, and the surface of the eyes,

dry eye syndrome

The best treatment for dry eye syndrome to cure depression.

TheraLife Eye offers a powerful solution to dry eye syndrome without the use of eye drops. Included in the TheraLife All-In-One Starter Kit:

  • TheraLife Eye Enhanced
  • TheraLife Omega-3 Fish Oil
  • Eye Lid Cleanser
  • Elasto-Gel Hot Compress

TheraLife Eye Enhanced

Restoring your eyes’ natural ability to produce tears, this FDA-approved tablet has been clinically proven to work for 80% of first-time users.  Complete with a 90-day money back guarantee, TheraLife Eye Enhanced heals the cells of the eyes by increasing the intracellular metabolism, membrane permeability, and blood circulation.  When the tear glands are stimulated, they will secrete tears naturally.

TheraLife Omega-3 Fish Oil – Molecularly Distilled.  100% Contaminant-free

When tears are thin, they don’t cover the ocular surface.  By using the purest fish oils that have been molecularly distilled, TheraLife Omega-3 Fish Oil thickens natural tears and prevents excess tear evaporation.  As we age, our body produces less natural acids that our eyes need to function properly.  TheraLife Omega-3 Fish Oil replaces these protective acids and aids in overall healthier eyes.

Eye Lid Cleanser

Clean eyes are healthy eyes.  Therefore, TheraLife includes a gentle, refreshing, and soothing cleaner for the eyelids and eyelashes.  Daily use helps prevent serious eye conditions, such as Blepharitis and Chronic Dry Eye Syndrome, from developing.  Made with HyChlor- an all natural products which prevent re-attachments of bacteria and mites to stop blepharitis forever. Our eyelid cleanser contains no detergents which can cause soreness of eyelids.

Hot Compress

A natural solution that provides relief for those suffering with chronic dry eyes, a hot compress is included in the TheraLife All-In-One Starter Kit for immediate soothing for dry, irritated eyes.  Made of Elastogel, our hot compress retains heat and is easy to clean.

Get your life back on track today.  Call us toll-free 1-877-917-1989 US/Canada) and talk to a doctor.  Email to [email protected]

References

 

1. Papas  EB.  The global prevalence of dry eye disease: a Bayesian view.   Ophthalmic Physiol Opt. 2021;41(6):1254-1266. doi:10.1111/opo.12888PubMedGoogle ScholarCrossref
2.Miljanović  B, Dana  R, Sullivan  DA, Schaumberg  DA.  Impact of dry eye syndrome on vision-related quality of life.   Am J Ophthalmol. 2007;143(3):409-415. doi:10.1016/j.ajo.2006.11.060PubMedGoogle ScholarCrossref
3.Pouyeh  B, Viteri  E, Feuer  W,  et al.  Impact of ocular surface symptoms on quality of life in a United States Veterans Affairs population.   Am J Ophthalmol. 2012;153(6):1061-66.e3. doi:10.1016/j.ajo.2011.11.030PubMedGoogle ScholarCrossref
4.Wan  KH, Chen  LJ, Young  AL.  Depression and anxiety in dry eye disease: a systematic review and meta-analysis.   Eye (Lond). 2016;30(12):1558-1567. doi:10.1038/eye.2016.186PubMedGoogle ScholarCrossref

5.Vehof  J, Kozareva  D, Hysi  PG,  et al.  Relationship between dry eye symptoms and pain sensitivity.   JAMA Ophthalmol. 2013;131(10):1304-1308. doi:10.1001/jamaophthalmol.2013.4399

6.Wei  Y, Asbell  PA.  The core mechanism of dry eye disease is inflammation.   Eye Contact Lens. 2014;40(4):248-256. doi:10.1097/ICL.0000000000000042PubMedGoogle ScholarCrossref
7.Kiecolt-Glaser  JK, Derry  HM, Fagundes  CP.  Inflammation: depression fans the flames and feasts on the heat.   Am J Psychiatry. 2015;172(11):1075-1091. doi:10.1176/appi.ajp.2015.15020152PubMedGoogle ScholarCrossref
8.Galor  A, Feuer  W, Lee  DJ,  et al.  Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database.   Am J Ophthalmol. 2012;154(2):340-346.e2. doi:10.1016/j.ajo.2012.02.009PubMedGoogle ScholarCrossref
9. Kim  KW, Han  SB, Han  ER,  et al.  Association between depression and dry eye disease in an elderly population.   Invest Ophthalmol Vis Sci. 2011;52(11):7954-7958. doi:10.1167/iovs.11-8050PubMedGoogle ScholarCrossref
10. Labbé  A, Wang  YX, Jie  Y, Baudouin  C, Jonas  JB, Xu  L.  Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study.   Br J Ophthalmol. 2013;97(11):1399-1403. doi:10.1136/bjophthalmol-2013-303838PubMedGoogle ScholarCrossref
11. Fernandez  CA, Galor  A, Arheart  KL,  et al.  Dry eye syndrome, posttraumatic stress disorder, and depression in an older male veteran population.   Invest Ophthalmol Vis Sci. 2013;54(5):3666-3672. doi:10.1167/iovs.13-11635PubMedGoogle ScholarCrossref
12. Bitar  MS, Olson  DJ, Li  M, Davis  RM.  The correlation between dry eyes, anxiety and depression: the Sicca, Anxiety and Depression Study.   Cornea. 2019;38(6):684-689. doi:10.1097/ICO.0000000000001932PubMedGoogle ScholarCrossref
13. Asbell  PA, Maguire  MG, Pistilli  M,  et al; Dry Eye Assessment and Management Study Research Group.  n-3 Fatty acid supplementation for the treatment of dry eye disease.   N Engl J Med. 2018;378(18):1681-1690. doi:10.1056/NEJMoa1709691PubMedGoogle ScholarCrossref
14. Asbell  PA, Maguire  MG, Peskin  E, Bunya  VY, Kuklinski  EJ; Dry Eye Assessment and Management (DREAM©) Study Research Group.  Dry Eye Assessment and Management (DREAM©) Study: study design and baseline characteristics.   Contemp Clin Trials. 2018;71:70-79. doi:10.1016/j.cct.2018.06.002PubMedGoogle ScholarCrossref
15. von Elm  E, Altman  DG, Egger  M, Pocock  SJ, Gøtzsche  PC, Vandenbroucke  JP; STROBE Initiative.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.   Ann Intern Med. 2007;147(8):573-577. doi:10.7326/0003-4819-147-8-200710160-00010PubMedGoogle ScholarCrossref

16. Schiffman  RM, Christianson  MD, Jacobsen  G, Hirsch  JD, Reis  BL.  Reliability and validity of the Ocular Surface Disease Index.   Arch Ophthalmol. 2000;118(5):615-621. doi:10.1001/archopht.118.5.615

17. Cleeland  CS, Ryan  KM.  Pain assessment: global use of the Brief Pain Inventory.   Ann Acad Med Singap. 1994;23(2):129-138.PubMedGoogle Scholar
18. Sayegh  RR, Yu  Y, Farrar  JT,  et al.  Ocular discomfort and quality of life among patients in the Dry Eye Assessment and Management Study.   Cornea. 2021;40(7):869-876. doi:10.1097/ICO.0000000000002580PubMedGoogle ScholarCrossref
19. Lemp  MA.  Report of the National Eye Institute/industry workshop on clinical trials in dry eyes.   CLAO J. 1995;21(4):221-232.PubMedGoogle Scholar
20. Daniel  E, Maguire  MG, Pistilli  M,  et al; Dry Eye Assessment and Management (DREAM) Study Research Group.  Grading and baseline characteristics of meibomian glands in meibography images and their clinical associations in the Dry Eye Assessment and Management (DREAM) study.   Ocul Surf. 2019;17(3):491-501. doi:10.1016/j.jtos.2019.04.003PubMedGoogle ScholarCrossref
21. Roy  NS, Wei  Y, Yu  Y,  et al; for the Dry Eye Assessment and Management (DREAM) Study Group.  Conjunctival HLA-DR expression and its association with symptoms and signs in the DREAM Study.   Transl Vis Sci Technol. 2019;8(4):31. doi:10.1167/tvst.8.4.31PubMedGoogle ScholarCrossref
22. Roy  NS, Wei  Y, Kuklinski  E, Asbell  PA.  The growing need for validated biomarkers and endpoints for dry eye clinical research.   Invest Ophthalmol Vis Sci. 2017;58(6):BIO1-BIO19. doi:10.1167/iovs.17-21709PubMedGoogle ScholarCrossref
23. Wei  Y, Gadaria-Rathod  N, Epstein  S, Asbell  P.  Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures.   Invest Ophthalmol Vis Sci. 2013;54(13):8327-8336. doi:10.1167/iovs.13-12132PubMedGoogle ScholarCrossref
24. Ware  JE, Kosinski  M, Keller  SF.  SF-36 Physical and Mental Health Summary Scales: A User’s Manual. The Health Institute; 1994.
25. Maruish  ME.  Handbook of Psychological Assessment in Primary Care Settings. Routledge, Taylor & Francis Group; 2017.
26. Beusterien  KM, Steinwald  B, Ware  JE  Jr.  Usefulness of the SF-36 Health Survey in measuring health outcomes in the depressed elderly.   J Geriatr Psychiatry Neurol. 1996;9(1):13-21. doi:10.1177/089198879600900103PubMedGoogle ScholarCrossref
27. Walsh  TL, Homa  K, Hanscom  B, Lurie  J, Sepulveda  MG, Abdu  W.  Screening for depressive symptoms in patients with chronic spinal pain using the SF-36 Health Survey.   Spine J. 2006;6(3):316-320. doi:10.1016/j.spinee.2005.11.004PubMedGoogle ScholarCrossref
28. Stoll  T, Kauer  Y, Büchi  S, Klaghofer  R, Sensky  T, Villiger  PM.  Prediction of depression in systemic lupus erythematosus patients using SF-36 Mental Health scores.   Rheumatology (Oxford). 2001;40(6):695-698. doi:10.1093/rheumatology/40.6.695PubMedGoogle ScholarCrossref
29. Wang  WL, Liang  S, Zhu  FL,  et al.  The prevalence of depression and the association between depression and kidney function and health-related quality of life in elderly patients with chronic kidney disease: a multicenter cross-sectional study.   Clin Interv Aging. 2019;14:905-913. doi:10.2147/CIA.S203186PubMedGoogle ScholarCrossref
30. Sullivan  BD, Whitmer  D, Nichols  KK,  et al.  An objective approach to dry eye disease severity.   Invest Ophthalmol Vis Sci. 2010;51(12):6125-6130. doi:10.1167/iovs.10-5390PubMedGoogle ScholarCrossref
31. Ong  ES, Felix  ER, Levitt  RC, Feuer  WJ, Sarantopoulos  CD, Galor  A.  Epidemiology of discordance between symptoms and signs of dry eye.   Br J Ophthalmol. 2018;102(5):674-679. doi:10.1136/bjophthalmol-2017-310633PubMedGoogle ScholarCrossref
32. Vehof  J, Sillevis Smitt-Kamminga  N, Nibourg  SA, Hammond  CJ.  Predictors of discordance between symptoms and signs in dry eye disease.   Ophthalmology. 2017;124(3):280-286. doi:10.1016/j.ophtha.2016.11.008PubMedGoogle ScholarCrossref
33. Shiboski  SC, Shiboski  CH, Criswell  L,  et al; Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups.  American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort.   Arthritis Care Res (Hoboken). 2012;64(4):475-487. doi:10.1002/acr.21591PubMedGoogle ScholarCrossref
34. Yu  K, Bunya  V, Maguire  M, Asbell  P, Ying  GS; Dry Eye Assessment and Management Study Research Group.  Systemic conditions associated with severity of dry eye signs and symptoms in the Dry Eye Assessment and Management Study.   Ophthalmology. 2021;128(10):1384-1392. doi:10.1016/j.ophtha.2021.03.030PubMedGoogle ScholarCrossref

35. Okereke  OI, Vyas  CM, Mischoulon  D,  et al.  Effect of long-term supplementation with marine omega-3 fatty acids vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial.   JAMA. 2021;326(23):2385-2394. doi:10.1001/jama.2021.21187

36. Rosner  B, Glynn  RJ, Lee  MLT.  The Wilcoxon signed rank test for paired comparisons of clustered data.   Biometrics. 2006;62(1):185-192. doi:10.1111/j.1541-0420.2005.00389.xPubMedGoogle ScholarCrossref
37. Kawashima  M, Uchino  M, Yokoi  N,  et al.  Associations between subjective happiness and dry eye disease: a new perspective from the Osaka study.   PLoS One. 2015;10(4):e0123299. doi:10.1371/journal.pone.0123299PubMedGoogle ScholarCrossref
38.   The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007).   Ocul Surf. 2007;5(2):93-107. doi:10.1016/S1542-0124(12)70082-4PubMedGoogle ScholarCrossref
39. Madhav  KC, Sherchand  SP, Sherchan  S.  Association between screen time and depression among US adults.   Prev Med Rep. 2017;8:67-71. doi:10.1016/j.pmedr.2017.08.005PubMedGoogle ScholarCrossref
40. Makhija  K, Karunakaran  S.  The role of inflammatory cytokines on the aetiopathogenesis of depression.   Aust N Z J Psychiatry. 2013;47(9):828-839. doi:10.1177/0004867413488220PubMedGoogle ScholarCrossref
41. Mrugacz  M, Ostrowska  L, Bryl  A, Szulc  A, Zelazowska-Rutkowska  B, Mrugacz  G.  Pro-inflammatory cytokines associated with clinical severity of dry eye disease of patients with depression.   Adv Med Sci. 2017;62(2):338-344. doi:10.1016/j.advms.2017.03.003PubMedGoogle ScholarCrossref

42. Schaumberg  DA, Dana  R, Buring  JE, Sullivan  DA.  Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies.   Arch Ophthalmol. 2009;127(6):763-768. doi:10.1001/archophthalmol.2009.103

43. Wong  J, Lan  W, Ong  LM, Tong  L.  Non-hormonal systemic medications and dry eye.   Ocul Surf. 2011;9(4):212-226. doi:10.1016/S1542-0124(11)70034-9PubMedGoogle ScholarCrossref

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

Pin It on Pinterest